tradingkey.logo

Aclarion Inc

ACON

7.115USD

+0.120+1.72%
Horário de mercado ETCotações atrasadas em 15 min
4.14MValor de mercado
PerdaP/L TTM

Aclarion Inc

7.115

+0.120+1.72%
Mais detalhes de Aclarion Inc Empresa
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.
Informações da empresa
Código da empresaACON
Nome da EmpresaAclarion Inc
Data de listagemApr 22, 2022
CEOMr. Brent Ness
Número de funcionários6
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 22
Endereço8181 Arista Place
CidadeBROOMFIELD
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal80021
Telefone18332752266
Sitehttps://aclarion.com/
Código da empresaACON
Data de listagemApr 22, 2022
CEOMr. Brent Ness
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jeffrey John Thramann, M.D.
Dr. Jeffrey John Thramann, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
10.00
--
Mr. Brent Ness
Mr. Brent Ness
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.00
--
Mr. Ryan Bond
Mr. Ryan Bond
Chief Strategy Officer
Chief Strategy Officer
1.00
--
Mr. Steve Deitsch
Mr. Steve Deitsch
Independent Director
Independent Director
--
--
Ms. Amanda Williams
Ms. Amanda Williams
Independent Director
Independent Director
--
--
Mr. William Wesemann
Mr. William Wesemann
Lead Independent Director
Lead Independent Director
--
--
Dr. Scott Breidbart, M.D.
Dr. Scott Breidbart, M.D.
Independent Director
Independent Director
--
--
Mr. David Neal
Mr. David Neal
Director
Director
--
--
Mr. John Lorbiecki
Mr. John Lorbiecki
Chief Financial Officer
Chief Financial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jeffrey John Thramann, M.D.
Dr. Jeffrey John Thramann, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
10.00
--
Mr. Brent Ness
Mr. Brent Ness
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.00
--
Mr. Ryan Bond
Mr. Ryan Bond
Chief Strategy Officer
Chief Strategy Officer
1.00
--
Mr. Steve Deitsch
Mr. Steve Deitsch
Independent Director
Independent Director
--
--
Ms. Amanda Williams
Ms. Amanda Williams
Independent Director
Independent Director
--
--
Mr. William Wesemann
Mr. William Wesemann
Lead Independent Director
Lead Independent Director
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qui, 29 de mai
Atualizado em: qui, 29 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Geode Capital Management, L.L.C.
0.05%
Other
99.95%
Investidores
Investidores
Proporção
Geode Capital Management, L.L.C.
0.05%
Other
99.95%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
0.07%
Other
99.93%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
17
476.00
0.08%
+84.00
2025Q1
19
368.00
0.06%
+366.00
2024Q4
16
3.00
0.00%
-7.00
2024Q3
21
2.00
0.00%
-10.00
2024Q2
27
2.00
7.77%
-3.00
2024Q1
28
3.00
9.70%
--
2023Q4
35
1.00
14.29%
-1.00
2023Q3
34
1.00
25.00%
-1.00
2023Q2
33
1.00
25.00%
-1.00
2023Q1
25
1.00
25.00%
-1.00
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Geode Capital Management, L.L.C.
391.00
0.07%
--
--
May 31, 2025
UBS Financial Services, Inc.
52.00
0.01%
+52.00
--
Mar 31, 2025
Thramann (Jeffrey John)
10.00
0%
+10.00
--
May 09, 2025
Morgan Stanley & Co. LLC
5.00
0%
+5.00
--
Mar 31, 2025
BofA Global Research (US)
4.00
0%
+4.00
--
Mar 31, 2025
Clear Street LLC
3.00
0%
+3.00
--
Mar 31, 2025
Tower Research Capital LLC
3.00
0%
+3.00
--
Mar 31, 2025
Ness (Brent)
3.00
0%
+3.00
--
May 09, 2025
Neal (David K)
2.00
0%
+2.00
--
May 09, 2025
Wesemann (William G)
1.00
0%
+1.00
--
May 09, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Mar 26, 2025
Merger
27<1
Mar 26, 2025
Merger
27<1
Mar 26, 2025
Merger
27<1
Mar 26, 2025
Merger
27<1
Jan 24, 2025
Merger
335<1
Jan 24, 2025
Merger
335<1
Data
Tipo
Proporção
Mar 26, 2025
Merger
27<1
Mar 26, 2025
Merger
27<1
Mar 26, 2025
Merger
27<1
Mar 26, 2025
Merger
27<1
Jan 24, 2025
Merger
335<1
Jan 24, 2025
Merger
335<1
Jan 24, 2025
Merger
335<1
Jan 24, 2025
Merger
335<1
Jan 02, 2024
Merger
16<1
Jan 02, 2024
Merger
16<1
Ver Mais
KeyAI